Ultralife Corporation Reports Second Quarter Results

Profitability and backlog hit records, but sales growth remains flat at Ultralife Corporation.

What the company is saying

Ultralife Corporation presents its second quarter 2026 results as a story of improved profitability and operational execution, despite a slight dip in sales. The narrative emphasizes a record backlog of $117.5 million and significant margin expansion, with gross profit rising to $13.9 million (28.9% of revenue) from $11.6 million (23.9%) a year earlier. Management highlights the transition of several product development programs into production later in the year, framing this as a driver for future growth. The announcement foregrounds adjusted EBITDA growth to $6.1 million and a tripling of GAAP EPS to $0.15, while acknowledging one-time items such as a $1.1 million IEEPA refund and $0.9 million in non-recurring costs. The tone is confident and focused on operational metrics, with forward-looking statements kept proportionate and tied to near-term execution. There is no mention of new M&A, dividends, or share repurchases, and no detailed breakdown by customer or geography is provided.

What the data suggests

The reported numbers show Ultralife's sales declined slightly year-over-year, from $48.6 million to $47.9 million, but profitability improved sharply. Gross profit increased by $2.3 million, and gross margin expanded by 5 percentage points to 28.9%, or 26.6% excluding a $1.1 million refund. Operating income rose to $3.4 million, up from $2.3 million, despite higher one-time costs. GAAP EPS reached $0.15, up from $0.05, and adjusted EBITDA climbed 49% to $6.1 million. The backlog grew to $117.5 million, a record high, indicating strong future demand. Segment analysis reveals Battery & Energy Products sales fell 3.7% to $44.2 million, while Communications Systems sales jumped 39.3% to $3.8 million. Balance sheet data shows cash declined to $6.7 million from $9.3 million at year-end, inventories increased to $58.7 million, and total debt decreased. The company does not provide full-year guidance or customer/geographic breakdowns, but the quality and completeness of quarterly disclosures are high.

Analysis

The announcement is primarily focused on realised, measurable financial results for the second quarter of 2026, including sales, gross profit, operating income, net income, and adjusted EBITDA, all of which are supported by detailed numerical disclosures. The only forward-looking claims are limited to product development programs expected to transition into production later this year, which are clearly separated from the realised results. There is no evidence of exaggerated or promotional language; the tone is positive but proportionate to the actual improvements in profitability and backlog. No large capital outlay or long-dated, uncertain returns are disclosed in this announcement. The gap between narrative and evidence is minimal, as all key claims are substantiated by the provided data.

Risk flags

• ●Sales growth is stagnant, with total revenue down slightly year-over-year and Battery & Energy Products declining 3.7%. This raises questions about the sustainability of profitability improvements if top-line growth does not resume.
• ●Cash on hand decreased from $9.3 million at year-end to $6.7 million, while inventories rose to $58.7 million. This could signal working capital pressures if inventory turns do not improve or if backlog conversion is delayed.
• ●The company does not provide a customer or geographic revenue breakdown, limiting visibility into concentration risks or exposure to specific end markets. This lack of granularity could obscure underlying volatility.
• ●Profitability improvements partially rely on a $1.1 million IEEPA refund and higher gross margins. If these one-time items are not repeated, margin levels may revert, especially if input costs rise or pricing pressure increases.
• ●Forward-looking statements about new product launches and backlog execution are subject to typical risks, including delays in customer acceptance, supply chain disruptions, or changes in government/defense spending. The company itself cites these as potential uncertainties.

Bottom line

Ultralife's Q2 2026 results show the company is delivering on profitability, with gross margin, operating income, and adjusted EBITDA all posting strong gains despite flat sales. The record $117.5 million backlog and near-term product launches support management's outlook for continued growth, but the lack of sales momentum and declining cash position introduce caution. No evidence of hype or overstatement appears in the announcement, and all key claims are substantiated by detailed financials. To increase confidence, the company would need to demonstrate sustained sales growth and provide more granular disclosure on customer and geographic mix. The most important takeaway is that while operational execution is improving, future upside depends on converting backlog into revenue and reigniting top-line growth.

Announcement summary

(NASDAQ: ULBI) Ultralife Corporation reported operating results for the second quarter ended June 30, 2026, with sales of $47.9 million compared to $48.6 million for the 2025 second quarter. Gross profit was $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund, gross margin was 26.6%. Operating income was $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter. GAAP EPS was $0.15 compared to $0.05 for the 2025 second quarter, and adjusted EBITDA was $6.1 million compared to $4.1 million for the 2025 second quarter. The backlog at the end of the second quarter was $117.5 million, the highest in the company’s history, compared to $115.1 million exiting the first quarter of 2026 and $84.5 million exiting the second quarter of 2025. Battery & Energy Products sales decreased 3.7% to $44.2 million, while Communications Systems sales increased by 39.3% to $3.8 million. The company projects several product development programs are expected to transition into production later this year while continuing to execute its backlog.

Disagree with this article?